Results 191 to 200 of about 177,862 (267)
High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease
Abstract Background DOPA decarboxylase (DDC) in cerebrospinal fluid (CSF) is an emerging Parkinson's disease (PD) biomarker, but its association with nonmotor symptoms is unclear. Objectives We aimed to determine if baseline DDC was associated with future cognitive decline in PD.
Andrea Sturchio +7 more
wiley +1 more source
Rotenone targets midbrain astrocytes to produce glial dysfunction-mediated dopaminergic neurodegeneration. [PDF]
Miyazaki I +10 more
europepmc +1 more source
Non‐Dopaminergic Pathology of Parkinson's Disease
Heiko Braak, Kelly Del Tredici
openalex +1 more source
Abstract Background Findings are contradictory regarding changes in the incidence and prevalence of Parkinson's disease (PD) over time; data for other parkinsonian disorders are rare. Objectives To analyze temporal trends in the incidence and prevalence of eight parkinsonisms (PD, MSA, PSP, CBS, DLB, vascular parkinsonism, drug‐induced parkinsonism ...
Sacha E. Gandhi +7 more
wiley +1 more source
Diet for the prevention and treatment of Parkinson's disease. [PDF]
Chen W, Fan T, Xu R.
europepmc +1 more source
Synergetic effect of a DSP4-induced locus coeruleus lesion and systemic LPS exacerbates substantia nigra dopaminergic neuron loss. [PDF]
Şimşek F +7 more
europepmc +1 more source
Abstract Background In modern medicine the concept of wellness is often accompanied by various misconceptions arising from several factors, including a lack of clear definitions, the commercialization of wellness, and prevailing biases and stereotypes.
Indu Subramanian +40 more
wiley +1 more source
Isn't it ironic? Functional iron deficiency at the core of Parkinson's disease pathobiology. [PDF]
Peikon I, Andrews NC.
europepmc +1 more source

